Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

SLGN vs ATR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ATR Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

ATR Overall Winner 6-Pillar Tally: SLGN 1 – 5 ATR Matrix Metrics: SLGN 3 – 7 ATR

As of Nov 17, 2026, AptarGroup, Inc. (ATR) is the stronger overall head-to-head candidate over Silgan Holdings Inc (SLGN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SLGN carries a Unified Composite Score of 32.3/100 (SELL) at $40.30 (10.1x Forward P/E, 9.7% operating margin), whereas ATR carries 39.6/100 (SELL) at $140.93 (23.1x Forward P/E, 12.4% operating margin).

  • Defensive Composite Rating Caution: Although ATR compares more favorably head-to-head, both SLGN (32.3/100 SELL) and ATR (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SLGN vs ATR
SLGN NYSE
Silgan Holdings Inc
Metal Cans
$40.30
-0.99% 1D
Market Cap $4.3B
TTM Revenue $6.71B
Forward P/E 10.1x
Beta / 30D Vol 0.60β · 34% Vol
Unified Composite Score
32.3 / 100 SELL
Tech 34.0 Fund 42.0 Flow 54.0 Mom 36.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.1 · SMA20: $40.55 · SMA50: $38.29
ATR NYSE Head-to-Head Winner
AptarGroup, Inc.
Plastics Products, Nec
$140.93
-1.57% 1D
Market Cap $9.1B
TTM Revenue $3.99B
Forward P/E 23.1x
Beta / 30D Vol 0.34β · 30% Vol
Unified Composite Score
39.6 / 100 SELL
Tech 24.0 Fund 37.0 Flow 54.0 Mom 31.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 62
RSI-14: 62.3 · SMA20: $137.46 · SMA50: $128.70

6-Pillar Scorecard Institutional Category Breakdown (SLGN 1 – 5 ATR)

Columns: Metric · SLGN · ATR
1. Valuation Multiples SLGN
Forward P/E 10.1x 23.1x
Trailing P/E 16.5x 34.6x
PEG Ratio 0.84x 3.14x
EV / Revenue 1.3x 2.6x
2. Growth & Scale ATR
Revenue Growth (YoY) +1.6% +6.0%
Earnings Growth (YoY) -6.6% -73.4%
TTM Revenue (USD) $6.71B $3.99B
Market Cap $4.3B $9.1B
3. Profitability & Quality ATR
Gross Margin 17.0% 35.8%
Operating Margin 9.7% 12.4%
Net Profit Margin 3.9% 6.7%
Return on Equity (ROE) 11.0% 9.8%
4. Balance Sheet & Cash Flow ATR
Cash Generation (TTM) $347M $801M EBITDA
Cash Flow Margin 5.2% 20.1% EBITDA Mgn
Net Cash / Leverage $4.22B Net Debt (1.84x D/E) $1.21B Net Debt (0.54x D/E)
Dividend Yield 2.04% 1.35%
5. Options & Positioning ATR
Options Structure Phase CONSOLIDATION SURGE
Current IV / %ile 25.4% (12th %ile) 24.6% (22nd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat ATR
OpEx & R&D Intensity 7.3% of Rev ($490M) 23.4% of Rev ($934M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaging & Containers Operator Medical Instruments & Supplies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SLGN (3) vs ATR (7)
Institutional Metric SLGN ATR Criterion Row Edge
Market Capitalization
Scale
$4.3B $9.1B Larger Scale ATR
Trailing P/E Ratio
Valuation
16.5x 34.6x Lower Multiple SLGN
Forward P/E Ratio
Valuation
10.1x 23.1x Lower Multiple SLGN
Revenue Growth (YoY)
Growth
+1.6% +6.0% Higher Growth ATR
Operating Margin (TTM)
Profitability
9.7% 12.4% Higher Margin ATR
Net Profit Margin
Profitability
3.9% 6.7% Higher Margin ATR
Return on Equity (ROE)
Capital Efficiency
11.0% 9.8% Higher ROE SLGN
52-Week Range Position
Momentum
42% ($34–$50) 80% ($111–$149) Stronger Trend ATR
Beta / 30D Volatility
Risk Regime
0.60β · 34% Vol 0.34β · 30% Vol Lower Realized Risk ATR
Unified Institutional Score
Composite Signal
32.3 / 100 (SELL) 39.6 / 100 (SELL) Higher Composite ATR
Trailing 12M Revenue (USD)
Operating Scale
$6.71B $3.99B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.0% 35.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.84x PEG · 1.3x EV/Rev 3.14x PEG · 2.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$347M ($4.22B Net Debt (1.84x D/E)) $801M EBITDA ($1.21B Net Debt (0.54x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ATR +12.46 pp
SLGN: +0.61% · ATR: +13.07%
3M Horizon ATR +8.16 pp
SLGN: -2.15% · ATR: +6.01%
6M Horizon ATR +15.37 pp
SLGN: +8.67% · ATR: +24.04%
1Y Horizon ATR +12.72 pp
SLGN: +6.09% · ATR: +18.81%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SLGN Revenue ATR Revenue SLGN Op. Margin ATR Op. Margin Margin Leader
FY2018 $4.45B $2.76B 9.3% 10.4% ATR
FY2019 $4.49B $2.86B 8.0% 13.0% ATR
FY2020 $4.92B $2.93B 6.3% 11.6% ATR
FY2021 $5.68B $3.23B 6.3% 10.8% ATR
FY2022 $6.41B $3.32B 5.3% 11.4% ATR
FY2023 $5.99B $3.49B 5.4% 11.6% ATR
FY2024 $5.85B $3.58B 4.7% 13.9% ATR
FY2025 $6.48B $3.78B 4.4% 13.3% ATR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SLGN CONSOLIDATION
79d in phase · OBV DISTRIBUTION
Current IV 25.4%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SLGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ATR SURGE
9d in phase · OBV DISTRIBUTION
Current IV 24.6%
IV Percentile 22nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact ATR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SLGN Moat Profile Cyclical / Execution-Driven Positioning
Packaging & Containers Operator
Competes within the Packaging & Containers value chain with $4.3B market capitalization and 9.7% operating margin.
OpEx & R&D Reinvestment 7.3% of Rev ($490M)
90D Engineering Disclosures 0 Published
ATR Moat Profile Cyclical / Execution-Driven Positioning
Medical Instruments & Supplies Operator
Competes within the Medical Instruments & Supplies value chain with $9.1B market capitalization and 12.4% operating margin.
OpEx & R&D Reinvestment 23.4% of Rev ($934M)
90D Engineering Disclosures 0 Published

Investor FAQ SLGN vs ATR Key Questions & Quantitative Answers

As of Nov 17, 2026, AptarGroup, Inc. (ATR) is the stronger overall head-to-head candidate over Silgan Holdings Inc (SLGN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SLGN carries a Unified Composite Score of 32.3/100 (SELL) at $40.30 (10.1x Forward P/E, 9.7% operating margin), whereas ATR carries 39.6/100 (SELL) at $140.93 (23.1x Forward P/E, 12.4% operating margin). Defensive Composite Rating Caution: Although ATR compares more favorably head-to-head, both SLGN (32.3/100 SELL) and ATR (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

ATR leads the Growth & Scale pillar: SLGN posts +1.6% YoY revenue growth and -6.6% YoY earnings growth on $6.71B TTM revenue (17.0% gross margin, 9.7% operating margin), compared with ATR at +6.0% YoY revenue growth and -73.4% YoY earnings growth on $3.99B TTM revenue (35.8% gross margin, 12.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SLGN cumulative revenue shifted +45.6% while ATR shifted +37.0%. In operating R&D and SG&A reinvestment, SLGN deploys 7.3% of Rev ($490M) (0 90-day corporate R&D disclosures) versus 23.4% of Rev ($934M) (0 disclosures) for ATR.

SLGN screens cheaper on headline valuation multiples. SLGN trades at 10.1x Forward P/E, 16.5x Trailing P/E, 0.84x PEG, and 1.3x EV/Revenue (5.2% FCF margin), whereas ATR trades at 23.1x Forward P/E, 34.6x Trailing P/E, 3.14x PEG, and 2.6x EV/Revenue (20.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SLGN (11.0% ROE) versus ATR (9.8% ROE) capital efficiency.

In options market volatility and institutional positioning, SLGN carries 25.4% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.60β · 34% Vol realized risk). By comparison, ATR carries 24.6% implied volatility (22nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.34β · 30% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.